Open AccessRapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination
Author(s) -
Nutalapati Snigdha,
Gupta Garima,
Hildebrandt Gerhard C.
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5035
Subject(s) - medicine , romiplostim , mycophenolate , refractory (planetary science) , vaccination , immune thrombocytopenia , immune system , platelet , covid-19 , immunology , thrombopoietin , transplantation , disease , genetics , physics , stem cell , haematopoiesis , astrobiology , infectious disease (medical specialty) , biology
Vaccine mediated immune mediated thrombocytopenia (ITP) is exceedingly rare. We present a case of a young female who developed severe refractory ITP with multiple bleeding sites post second dose of COVID‐19 vaccination. She was treated with a combination of romiplostim and mycophenolate mofetil that resulted in rapid platelet count recovery.